New Sector Head Life Sciences at KPMG Switzerland
KPMG has appointed Martin Rohrbach as its new Sector Head Life Sciences. In this role, he coordinates all market activities in this important sector, which includes pharmaceuticals, biotechnology, medical research and diagnostics, and medtech.
Martin Rohrbach succeeds Erik Willems, who has successfully built up and developed the Life Sciences sector over the past years. "The life science industry needs new business models to find answers to megatrends such as demographic development, ever more rapidly changing customer needs, and digitalization. In addition, the industry must make contributions to other important issues concerning the future of the healthcare system," explains Martin Rohrbach. These include integrated solution approaches to improve the effectiveness of research and development, to make procurement chains more flexible or to ensure increased tax transparency, as well as challenges related to digitalization.
Martin Rohrbach has been with KPMG since 1998. Prior to that, the passionate alpinist and amateur photographer held various positions abroad, sometimes with a focus on capital market transactions. In the field of life sciences, the trained banker has many years of experience in advising companies of various sizes.
Source: KPMG
